News > Reliance Life Sciences to conduct trials for two-dose COVID-19 vaccine
Reliance Life Sciences to conduct trials for two-dose COVID-19 vaccine
27/08/2021 01:20 PM | Click to read full article
Reliance has now stepped into COVID-19 vaccine manufacturing. On Thursday the drug regulator approved Reliance Life Sciences' application to conduct clinical trials of its recombinant protein-based COVID-19 vaccine candidate.
Reliance had sought the regulator’s approval to conduct Phase 1 trial of its proposed two-dose vaccine, stated a report in The Economic Times. Reliance Life Sciences is yet to officially issue a statement.